Found: 42
Select item for more details and to access through your institution.
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 9, p. 670, doi. 10.1002/ajh.21788
- By:
- Publication type:
- Article
Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/jncics/pkz002
- By:
- Publication type:
- Article
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. 699, doi. 10.1093/oncolo/oyae072
- By:
- Publication type:
- Article
A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. 324, doi. 10.1093/oncolo/oyad298
- By:
- Publication type:
- Article
TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. 8, doi. 10.1093/oncolo/oyad208
- By:
- Publication type:
- Article
Circulating and intratumoral immune determinants of response to atezolizumab plus bevacizumab in patients with variant histology or sarcomatoid renal cell carcinoma.
- Published in:
- Oncologist, 2023, v. 28, p. S15, doi. 10.1093/oncolo/oyad216.026
- By:
- Publication type:
- Article
Novel M-component based biomarkers in Waldenström's macroglobulinemia.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 164, doi. 10.3816/CLML.2011.n.039
- By:
- Publication type:
- Article
Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 16, p. 2999, doi. 10.1002/cncr.28151
- By:
- Publication type:
- Article
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4777, doi. 10.1002/cncr.27416
- By:
- Publication type:
- Article
The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 365, doi. 10.1002/cncr.26201
- By:
- Publication type:
- Article
Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 12, p. 2637, doi. 10.1002/cncr.25750
- By:
- Publication type:
- Article
Time to Prostate-Specific Antigen Nadir Independently Predicts Overall Survival in Patients Who Have Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen-Deprivation Therapy.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 5, p. 981, doi. 10.1002/cncr.24064
- By:
- Publication type:
- Article
Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2340787, doi. 10.1001/jamanetworkopen.2023.40787
- By:
- Publication type:
- Article
Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 10, p. e2336390, doi. 10.1001/jamanetworkopen.2023.36390
- By:
- Publication type:
- Article
Neoadjuvant Novel Hormonal Therapy Followed by Prostatectomy versus Up-Front Prostatectomy for High-Risk Prostate Cancer: A Comparative Analysis.
- Published in:
- AUANews, 2022, v. 27, p. 16
- By:
- Publication type:
- Article
Association of genetic variation of the six gene prognostic model for castration‐resistant prostate cancer with survival.
- Published in:
- Prostate, 2019, v. 79, n. 1, p. 73, doi. 10.1002/pros.23712
- By:
- Publication type:
- Article
Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC).
- Published in:
- Prostate, 2018, v. 78, n. 12, p. 889, doi. 10.1002/pros.23645
- By:
- Publication type:
- Article
A Genetic Variation of SOD2 Does Not Determine Duration of Response to Androgen Deprivation Therapy for Prostate Cancer.
- Published in:
- Prostate, 2016, v. 76, n. 14, p. 1338, doi. 10.1002/pros.23220
- By:
- Publication type:
- Article
Association of Genetic Variations of Selenoprotein Genes, Plasma Selenium Levels, and Prostate Cancer Aggressiveness at Diagnosis.
- Published in:
- Prostate, 2016, v. 76, n. 7, p. 691, doi. 10.1002/pros.23160
- By:
- Publication type:
- Article
Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
- Published in:
- Prostate, 2013, v. 73, n. 4, p. 346, doi. 10.1002/pros.22572
- By:
- Publication type:
- Article
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 7, p. 519, doi. 10.1093/jnci/djp030
- By:
- Publication type:
- Article
Efficacy of Androgen Deprivation Therapy (ADT) in Patients With Advanced Prostate Cancer.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 6, p. 1247, doi. 10.1002/cncr.23304
- By:
- Publication type:
- Article
Higher Prostate-specific Antigen Levels Predict Improved Survival in Patients With Hormone-refractory Prostate Cancer Who Have Skeletal Metastases and Normal Serum Alkaline Phosphatase.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 12, p. 2709, doi. 10.1002/cncr.23111
- By:
- Publication type:
- Article
Response to low‐dose ketoconazole and subsequent dose escalation to high‐dose ketoconazole in patients with androgen‐independent prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 975
- By:
- Publication type:
- Article
Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high‐risk localized prostate cancer.
- Published in:
- Prostate, 2024, v. 84, n. 4, p. 342, doi. 10.1002/pros.24653
- By:
- Publication type:
- Article
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21068-9
- By:
- Publication type:
- Article
Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of outcomes for Hispanic and non‐Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 11, p. 2003, doi. 10.1002/cncr.35216
- By:
- Publication type:
- Article
Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1629, doi. 10.1002/cncr.35170
- By:
- Publication type:
- Article
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 840, doi. 10.1002/cncr.33328
- By:
- Publication type:
- Article
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 6, p. 843, doi. 10.1111/bjh.13382
- By:
- Publication type:
- Article
Formal Verification of mCWQ Using Extended Hoare Logic.
- Published in:
- Mobile Networks & Applications, 2019, v. 24, n. 1, p. 134, doi. 10.1007/s11036-018-1142-8
- By:
- Publication type:
- Article
Modeling and Verifying Basic Modules of Floodlight.
- Published in:
- Mobile Networks & Applications, 2019, v. 24, n. 1, p. 100, doi. 10.1007/s11036-018-1141-9
- By:
- Publication type:
- Article
Modeling and Verifying HDFS Using Process Algebra.
- Published in:
- Mobile Networks & Applications, 2017, v. 22, n. 2, p. 318, doi. 10.1007/s11036-017-0812-2
- By:
- Publication type:
- Article
Tracing the Timing of "Career" Acquisition in a Contemporary Youth Cohort.
- Published in:
- Work & Occupations, 2008, v. 35, n. 1, p. 44, doi. 10.1177/0730888407309761
- By:
- Publication type:
- Article
The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.
- Published in:
- BJU International, 2011, v. 108, n. 7, p. 1086, doi. 10.1111/j.1464-410X.2010.10037.x
- By:
- Publication type:
- Article
Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
- Published in:
- BJU International, 2011, v. 107, n. 1, p. 126, doi. 10.1111/j.1464-410X.2010.09344.x
- By:
- Publication type:
- Article